<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="49984">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02455518</url>
  </required_header>
  <id_info>
    <org_study_id>2014-4156</org_study_id>
    <nct_id>NCT02455518</nct_id>
  </id_info>
  <brief_title>Comparative Efficacy of 4 Oral Analgesics</brief_title>
  <official_title>Comparative Efficacy of 4 Oral Analgesics for the Initial Management of Acute Musculoskeletal Extremity Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to perform a randomized, double blind 4-arm clinical trial of
      the comparative efficacy of 4 oral analgesics in the initial management of acute
      musculoskeletal extremity pain presenting to the ED.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To perform a randomized, double blind 4-arm clinical trial of the comparative efficacy of 4
      oral analgesics in the initial management of acute musculoskeletal extremity pain presenting
      to the ED. The 4 groups are as follows:

        1. Oxycodone/acetaminophen (5/325)

        2. Hydrocodone/acetaminophen (5/325)

        3. Codeine/acetaminophen (30/300)

        4. Ibuprofen/acetaminophen (400/1000)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Between group difference in change in NRS pain scores</measure>
    <time_frame>1 hour</time_frame>
    <description>Change in NRS pre and 1 hour post receiving study medication while in the ED</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Between group difference in change in NRS pain scores</measure>
    <time_frame>2 hours</time_frame>
    <description>Change in NRS pre and 2 hours post receiving study medication while in the ED</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Oxycodone/acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oxycodone/acetaminophen (5 mg/325 mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydrocodone/acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hydrocodone/acetaminophen (5 mg/300 mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Codeine/acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Codeine/acetaminophen (30 mg/300 mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen/acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ibuprofen/acetaminophen (400 mg/1000 mg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone/acetaminophen</intervention_name>
    <arm_group_label>Oxycodone/acetaminophen</arm_group_label>
    <other_name>Percocet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocodone/acetaminophen</intervention_name>
    <arm_group_label>Hydrocodone/acetaminophen</arm_group_label>
    <other_name>Norco</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Codeine/acetaminophen</intervention_name>
    <arm_group_label>Codeine/acetaminophen</arm_group_label>
    <other_name>Tylenol with codeine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen/acetaminophen</intervention_name>
    <arm_group_label>Ibuprofen/acetaminophen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Complaint of acute pain of &lt; 7 days duration

          -  Location of pain in one or more extremities defined as distal to and including the
             shoulder joint in the upper extremities and distal to and including the hip joint in
             the lower extremities;

          -  Radiologic evaluation is planned

        Exclusion Criteria:

          -  Inability to confirm reliable means of phone followup.

          -  Past use of methadone

          -  Chronic condition requiring frequent pain management such as sickle cell disease,
             fibromyalgia, or any neuropathy

          -  History of an adverse reaction to any of the study medications

          -  Opioids taken in the past 24 hours

          -  Ibuprofen or acetaminophen taken in past 8 hours

          -  Pregnancy by either urine or serum HCG testing

          -  Breastfeeding per patient report

          -  History of peptic ulcer disease

          -  Report of any prior use of recreational narcotics

          -  Medical condition that might affect metabolism of opioid analgesics, acetaminophen,
             or ibuprofen such as hepatitis, renal insufficiency, hypo- or hyperthyroidism,
             Addison's or Cushing's disease

          -  Taking any medicine that might interact with one of the study medications, such as
             antidepressant SSRI's or Tricyclics, antipsychotics, anti-malaria medications
             quinidine or halofantrine, Amiodarone or Dronedarone, diphenhydramine, celecoxib,
             ranitidine, cimetidine, ritanovir, terbinafine, or St John's Wort.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andrew Chang, MD</last_name>
    <phone>718-920-2606</phone>
    <email>achang3@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Chang, MD</last_name>
      <phone>718-920-6626</phone>
      <email>achang3@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 15, 2016</lastchanged_date>
  <firstreceived_date>May 22, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Hydrocodone</mesh_term>
    <mesh_term>Codeine</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
